On November 27, 2024, Hakan Kardes, Chief Experience Officer at Alignment Healthcare Inc (ALHC, Financial), sold 35,000 shares of the company. Following this transaction, the insider now owns 320,444 shares of the company. The details of this transaction can be found in the SEC Filing.
Alignment Healthcare Inc (ALHC) is a company that provides healthcare services to seniors through its Medicare Advantage plans. The company focuses on improving the healthcare experience for its members by offering personalized care and innovative solutions.
Over the past year, Hakan Kardes has sold a total of 137,653 shares and has not purchased any shares. The insider transaction history for Alignment Healthcare Inc shows that there have been 1 insider buy and 56 insider sells over the same timeframe.
On the day of the recent sale, shares of Alignment Healthcare Inc were trading at $12.8, giving the stock a market cap of $2.417 billion. The stock's GF Value is estimated at $12.60, resulting in a price-to-GF-Value ratio of 1.02, indicating that the stock is fairly valued based on its GF Value.
The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also considers a GuruFocus adjustment factor based on the company’s past returns and growth, as well as future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
